Toxins VapC and pasB from prokaryotic TA modules remain active in mammalian cancer cells

Toxins

Volumn 6, Issue 10, 2014, Pages 2948-2961

  Wieteska, Łukasz ^a   Skulimowski, Aleksander ^a   Cybula, Magdalena ^a   Szemraj, Janusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cancer cells; Immunotoxin; PasB; Toxin antitoxin; VapC

Indexed keywords

BACTERIAL TOXIN; ENHANCED GREEN FLUORESCENT PROTEIN; HYGROMYCIN; LIPOFECTAMINE; MIFEPRISTONE; BACTERIAL PROTEIN; PASB PROTEIN, THIOBACILLUS FERROOXIDANS;

ACIDITHIOBACILLUS FERROOXIDANS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FLOW CYTOMETRY; GENE; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HORIZONTAL GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NONHUMAN; PASB GENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT; TOXIN ANALYSIS; TOXIN ANTITOXIN SYSTEM; VAPC GENE; WESTERN BLOTTING; BACTERIAL CHROMOSOME; CELL SURVIVAL; DRUG EFFECTS; GENETICS; HCT116 CELL LINE; MCF 7 CELL LINE; PLASMID; THIOBACILLUS; TUMOR CELL LINE;

ACIDITHIOBACILLUS FERROOXIDANS; MAMMALIA; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA;

APOPTOSIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMOSOMES, BACTERIAL; HCT116 CELLS; HUMANS; MCF-7 CELLS; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; THIOBACILLUS;

EID: 84922694514     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins6102948     Document Type: Article

References (31)

1. Guglielmini, J.; van Melderen, L. Bacterial toxin-antitoxin systems translation inhibitors everywhere. Mob. Genet. Elements 2011, 1, 283-290.
2. Hayes, F. Toxins-antitoxins: Plasmid maintenance, programmed cell death, and cell cycle arrest. Science 2003, 301, 1496-1499.
3. Fineran, P.C.; Blower, T.R.; Foulds, I.J.; Humphreys, D.P.; Lilley, K.S.; Salmond, G.P. The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc. Natl. Acad. Sci. USA 2009, 106, 894-899.
4. Tan, Q.; Awano, N.; Inouye, M. YeeV is an Escherichia coli toxin that inhibits cell division by targeting the cytoskeleton proteins, FtsZ and MreB. Mol. Microbiol. 2011, 79, 109-118.
5. Masuda, H.; Tan, Q.; Awano, N.; Wu, K.P.; Inouye, M. YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli. Mol. Microbiol. 2012, 84, 979-989.
6. Wang, X.; Lord, D.M.; Cheng, H.Y.; Osbourne, D.O.; Hong, S.H.; Sanchez-Torres, V.; Quiroga, C.; Zheng, K.; Herrmann, T.; Peti, W. A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat. Chem. Biol. 2012, 8, 855-861.
7. Sberro, H.; Leavitt, A.; Kiro, R.; Koh, E.; Peleg, Y.; Qimron, U.; Sorek, R. Discovery of functional toxin/antitoxin systems in bacteria by shotgun cloning. Mol. Cell 2013, 50, 136-148.
8. Goeders, N.; Van Melderen, L. Toxin-antitoxin systems as multilevel interaction systems. Toxins 2014, 6, 304-324.
9. Cook, G.M.; Robson, J.R.; Frampton, R.A.; McKenzie, J.; Przybilski, R.; Fineran, P.C.; Arcus, V.L. Ribonucleases in bacterial toxin-antitoxin systems. Biochim. Biophys. Acta 2013, 1829, 523-531.
10. Gerdes, K. Toxin-antitoxin modules may regulate synthesis of macromolecules during nutritional stress. J. Bacteriol. 2000, 182, 561-572.
11. Audoly, G.; Vincentell, R.; Edouard, S.; Georgiades, K.; Mediannikov, O.; Gimenez, G.; Socolovschi, C.; Mege, J.L.; Cambillau, C.; Raoult, D. Effect of Rickettsial Toxin VapC on Its Eukaryotic Host. PLoS One 2011, 6, doi:10.1371/journal.pone.0026528.
12. Ren, D.; Walker, A.N.; Daines, D.A. Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeable Haemophilus influenza. BMC Microbiol. 2012, 12, doi:10.1186/1471-2180-12-263.
13. Yamamoto, T.A.; Gerdes, K.; Tunnaclife, A. Bacterial toxin RelE induces apoptosis in human cell. FEBSLett. 2002, 22, 191-194.
14. De la Cueva-Mendez, G.; Mills, A.D.; Clay-Farrace, L.; Diaz-Orejas, R.; Laskey, R.A. Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis. EMBO J. 2003, 22, 246-251.
15. Li, G.Y.; Zhang, Y.; Chan, M.C.; Mal, T.K.; Hoeflich, K.P.; Inouye, M.; Ikura, M. Characterization of dual substrate binding sites in the homodimeric structure of Escherichia coli mRNA interferase MazF. J. Mol. Biol. 2006, 357, 139-150.
16. Kamada, K.; Hanaoka, F.; Burley, S.K. Crystal structure of the MazE/MazF complex: Molecular bases of antidote-toxin recognition. Mol. Cell 2003, 11, 875-884.
17. Erental, A.; Sharon, I.; Engelberg-Kulka, H. Two programmed cell death systems in Escherichia coli an apoptotic-like death is inhibited by the mazF mediated death pathway. PLoSBiol. 2012, 10, doi:10.1371/journal.pbio.1001281.
18. Hayes, F.; Kdzierska, B. Regulating toxin-antitoxin expression: Controlled detonation of intracellular molecular timebombs. Toxins 2014, 6, 337-358.
19. Ghafourian, S.; Good, L.; Sekawi, Z.; Hamat, R.A; Soheili, S.; Sadeghifard, N.; Neela, V. The mazEF toxin-antitoxin system as a novel antibacterial target in Acinetobacter baumannii. Mem. Inst. Oswaldo Cruz 2014, doi:10.1590/0074-0276130601.
20. Shapira, A.; Benhar, I. Toxin-based therapeutic approaches. Toxins 2010, 2, 2519-2583.
21. Shapira, A.; Shapira, S.; Gal-Tanamy, M.; Zemel, R.; Tur-Kaspa, R.; Benhar, I. Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin. PLoS One 2012, 7, doi:10.1371/journal.pone.0032320.
22. Okamoto, M.; Chono, H.; Kawano, Y.; Saito, N.; Tsuda, H.; Inoue, K.; Kato, I.; Mineno, J.; Baba, M. Sustained inhibition of HIV-1 replication by conditional expression of the E. coli—Derived endoribonuclease MazF in CD4+ T cells. Hum. Gene Ther. Methods 2013, 24, 94-103.
23. Deane, S.M.; Rawlings, D.E. Plasmid evolution and interaction between the plasmid addiction stability systems of two related broad host-range incQ-like plasmids. J. Bacteriol. 2004, 186, 2123-2133.
24. Cherny, I.; Overgaard, M.; Borch, J.; Bram, Y.; Gerdes, K.; Gazit, E. Structural and thermodynamic characterization of the Escherichia coli RelBE toxin-antitoxin system: indication for a functional role of differential stability. Biochemistry 2007, 46, 12152-12163.
25. Arcus, V.L.; McKenzie, J.L.; Robson, J.; Cook, G.M. The PIN-domain ribonucleases and the prokaryotic VapBC toxin-antitoxin array. Protein Eng. Des. Sel. 2011, 24, 33-40.
26. Ahidjo, B.A.; Kuhnert, D.; McKenzie, J.L.; Machowski, E.E.; Gordhan, B.G.; Arcus, V.; Abrahams, G.L.; Mizrahi, V. VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins. PLoS One 2011, 6, doi:10.1371/journal.pone.0021738.
27. Winther, K.S.; Gerdes, K. Enteric virulence associated protein VapC inhibits translation by cleavage of initiator tRNA. Proc. Natl. Acad. Sci. USA 2011, 108, 7403-7407.
28. McGuire, W.L.; Chamnes, G.C. Studies on the estrogen receptor in breast cancer. In Receptors for Reproductive Hormones; O'Malley, B.W., Chamnes, G.C., Eds.; Plenum Publishing Corporation: New York, NY, USA, 1973; pp. 113-136.
29. Andreev, D.; Hauryliuk, V.; Terenin, I.; Dmitriev, S.; Ehrenberg, M.; Shatsky, I. The bacterial toxin RelE induces specific mRNA cleavage in the A site of the eukaryote ribosome. RNA 2008, 14, 233-239.
30. Wu, C.C.; Tsai, F.M.; Shyu, R.Y.; Tsai, Y.M.; Wang, C.H.; Jiang, S.Y. G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells. BMC Cancer 2011, 11, doi:10.1186/1471-2407-11-175.
31. Green, M.R.; Sambrook, J. Molecular Cloning: A Laboratory Manual, 4th ed.; Cold Spring Harbor: New York, NY, USA, 2012.